NPI: 1104083393 · PANAMA CITY, FL 32401 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/16/2008
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 05/16/2008 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,897 | $1.75M |
| 2019 | 23,512 | $3.28M |
| 2020 | 23,157 | $2.69M |
| 2021 | 19,647 | $1.49M |
| 2022 | 9,250 | $1.40M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,257 | 1,304 | $3.39M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,491 | 1,673 | $2.84M |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,439 | 1,288 | $1.83M |
| A4657 | Syringe, with or without needle, each | 3,472 | 1,489 | $815K |
| J1756 | Injection, iron sucrose, 1 mg | 6,663 | 1,224 | $749K |
| 83970 | 1,792 | 957 | $193K | |
| 85048 | 1,496 | 980 | $158K | |
| 85041 | 1,534 | 978 | $157K | |
| 85045 | 992 | 671 | $105K | |
| 82728 | 897 | 571 | $99K | |
| 83540 | 894 | 581 | $97K | |
| 83550 | 855 | 554 | $93K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 292 | 153 | $44K |
| 82108 | 96 | 59 | $11K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 118 | 79 | $10K |
| G0009 | Administration of pneumococcal vaccine | 52 | 35 | $5K |
| 90732 | 31 | 18 | $4K | |
| 90670 | 31 | 23 | $4K | |
| 90662 | 20 | 12 | $3K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 25 | 12 | $3K |
| 86706 | 16 | 15 | $0.00 |